MoneyWorks4Me

A decent increase of about 74.82% in the turnover to Rs. 209.43 millions was observed for the quarter ended September 2022. The turnover stood at Rs. 119.80 millions during the similar quarter previous year.The Net Loss for the quarter ended September 2022 is Rs. -40.62 millions as compared to Net Loss of Rs. -108.49 millions of corresponding quarter ended September 2021 Operating profit Margin for the quarter ended September 2022 improved to -16.27% as compared to -76.57% of corresponding quarter ended September 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 209.43 119.80 74.82 315.84 187.35 68.58 597.03 537.00 11.18
Other Income 2.75 1.32 108.33 4.04 1.62 149.38 11.56 6.21 86.15
PBIDT -16.27 -76.57 -78.75 -77.66 -141.53 -45.13 -328.39 -169.56 93.67
Interest 7.42 17.76 -58.22 10.46 32.88 -68.19 53.91 62.79 -14.14
PBDT -23.69 -94.33 -74.89 -88.12 -174.41 -49.48 -382.30 -232.35 64.54
Depreciation 16.93 14.16 19.56 33.86 28.32 19.56 62.97 51.24 22.89
PBT -40.62 -108.49 -62.56 -121.98 -202.73 -39.83 -445.27 -283.59 57.01
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -40.62 -108.49 -62.56 -121.98 -202.73 -39.83 -445.27 -283.59 57.01
Equity 215.61 215.61 0.00 215.61 215.61 0.00 215.61 196.21 9.89
PBIDTM(%) -7.77 -63.91 -87.85 -24.59 -75.54 -67.45 -55.00 -31.58 74.20
Peers
Company Name CMP
Sun Pharma. Inds. 1856.25
Dr. Reddys Labs. 1205.00
Cipla 1402.50
Lupin 2099.00
Zydus Lifesciences 1175.00
View more..